# Telogen Effluvium: Causes, Stages, Timeline & Recovery

> Telogen effluvium is temporary diffuse hair shedding caused by physiological or emotional stress pushing hair.

*Telogen effluvium (TE) is one of the most common causes of diffuse, non-scarring hair loss. A triggering stressor — childbirth, fever, crash dieting, major surgery, thyroid dysfunction, or severe psychological stress — abruptly shifts a large proportion of anagen (growing) follicles into the telogen (resting) phase, causing noticeable shedding 2–3 months later. Acute TE resolves in approximately 95% of cases within 6–9 months once the trigger is removed. Chronic TE persists beyond 6 months, predominantly affects women aged 30–60, and requires systematic laboratory investigation.*

- Canonical: https://beautycomparison.com/telogen-effluvium-guide
- Reviewed: 2026-06-20
- Publisher: Beauty Comparison (Beauty Comparison Editorial) — independent, brand-neutral

## Key takeaways
- Telogen effluvium is triggered when physiological or emotional stress prematurely shifts growing hair follicles into the resting (telogen) phase — shedding begins 2–3 months after the triggering event, not at the time of the stressor.
- Under severe stress, approximately 70% of anagen hairs can enter telogen simultaneously, producing diffuse shedding of up to 300 hairs per day — far above the normal 50–100.
- Acute TE is self-limiting and resolves in around 95% of cases within 6–9 months once the underlying trigger is identified and addressed.
- Chronic TE is defined by shedding lasting longer than 6 months; it requires a systematic laboratory workup to exclude thyroid disorders, iron deficiency (serum ferritin <20 ng/mL), and other systemic causes.
- TE does not cause permanent hair loss or scarring — follicles are intact, and full regrowth is the expected outcome when the cause is corrected.
- Common triggers include postpartum hormonal change, fever or severe infection, major surgery, crash dieting, iron or protein deficiency, thyroid disorders, and psychological stress.

## What Is Telogen Effluvium?

Telogen effluvium (TE) is a form of non-scarring alopecia characterized by diffuse, often acute, shedding of scalp hair. It is one of the most prevalent causes of hair loss seen in clinical practice, yet it remains widely misunderstood — patients frequently present alarmed by dramatic hair fall weeks or months after a stressor they may not connect to their scalp.

The condition is not a disorder of the hair follicle itself. The follicles are structurally intact and fully capable of regrowth. What goes wrong is the timing of the growth cycle: a large cohort of actively growing hairs is prematurely pushed into the resting phase, and when those resting hairs are eventually shed, the volume of daily loss becomes conspicuous.

---

## Understanding the Hair Growth Cycle

To understand telogen effluvium, you need a working model of the hair growth cycle, which has three phases:

| Phase | Duration | Proportion of scalp hair |
|---|---|---|
| **Anagen** (growth) | ~2–5 years | ~85–90% |
| **Catagen** (transition) | ~3–6 weeks | ~1–3% |
| **Telogen** (resting/shedding) | ~3–5 months | ~10–15% |

During anagen, the hair matrix at the base of the follicle divides rapidly, pushing the hair shaft outward. The catagen phase is a brief transitional period during which cell division stops and the follicle regresses. In the telogen phase, the follicle rests and the old hair shaft is gradually displaced by a new anagen hair growing beneath it — this is what causes the natural daily shedding of 50–100 hairs in healthy individuals.

In telogen effluvium, a triggering event forces a significant proportion of anagen follicles to skip directly into the telogen phase. Under severe physiological stress, **up to 70% of anagen hairs can enter telogen simultaneously**, compared to the normal 10–15%. Two to three months later — the duration of the telogen phase — all of these hairs shed at once.

---

## The Five Types of Telogen Effluvium

Dermatologist John Headington described five distinct functional subtypes of TE based on the mechanism of follicle dysregulation:

1. **Immediate anagen release.** The most common form. Physiological stressors — fever, major illness, surgery — trigger cytokine-mediated apoptosis in hair bulb keratinocytes, abruptly ending the anagen phase. Shedding begins within 2–3 months.

2. **Delayed anagen release.** Classic postpartum hair loss. During pregnancy, elevated estrogen prolongs the anagen phase — hair grows thickly. After delivery, estrogen withdrawal causes a synchronised, mass entry into catagen and then telogen. Shedding peaks around 3–4 months postpartum.

3. **Short anagen syndrome.** An idiopathic inability to grow hair beyond a certain length due to a constitutionally shortened anagen phase. Hair never reaches normal length; the condition is poorly understood and may be partly hereditary.

4. **Immediate telogen release.** Paradoxically caused by treatments that stimulate anagen — particularly topical [minoxidil](/minoxidil-women-guide). Initiating minoxidil prematurely ends the telogen phase and triggers the resting hair to shed within 2–8 weeks. This is a sign the treatment is working, not a side effect to discontinue it for.

5. **Delayed telogen release.** Telogen hair is retained longer than normal, then released in a wave. This explains seasonal hair shedding that some people notice in autumn, possibly triggered by changes in photoperiod (light exposure).

---

## Causes and Triggers

Any significant physiological or psychological shock can trigger TE. The most frequently identified causes in clinical cohorts include:

### Physiological triggers
- **Childbirth** (postpartum TE is the most common single trigger)
- **High fever** — particularly from influenza, COVID-19, malaria, or other febrile illnesses
- **Major surgery** or general anaesthesia
- **Severe trauma** or haemorrhage
- **Rapid significant weight loss** (crash dieting, bariatric surgery)

### Nutritional causes
- **Iron deficiency** — serum ferritin below 20 ng/mL is a well-established precipitant; serum ferritin below 40 ng/mL may perpetuate TE even without frank anemia
- **Protein deficiency** — essential for hair shaft synthesis; inadequate intake manifests as TE 2–4 months later
- **Zinc deficiency**
- **Vitamin D deficiency**

### Endocrine and systemic causes
- **Hypothyroidism and hyperthyroidism** — both cause diffuse hair loss; TSH testing is standard in any TE workup
- **Systemic autoimmune conditions** (SLE, dermatomyositis)
- **Chronic infections** (HIV)

### Medications
A wide range of medications can trigger TE. Established causes include:
- Beta-blockers (propranolol, metoprolol)
- Retinoids (isotretinoin, acitretin)
- Anticoagulants (heparin, warfarin)
- Oral contraceptives (particularly on discontinuation)
- Antidepressants and mood stabilisers
- Anticonvulsants

### Psychological stress
Severe emotional stress — bereavement, relationship breakdown, job loss — is a recognized TE trigger, though the psychological pathway is less acutely dramatic than a high fever. The mechanism involves stress-hormone-mediated neuropeptide signalling (Substance P) and perifollicular immune activation that prematurely terminates the anagen phase.

---

## Symptoms

Telogen effluvium presents characteristically:

- **Diffuse shedding** — hair falls from across the entire scalp, not in patches
- **Volume of daily shedding** greatly increased — from the normal 50–100 hairs to upwards of 300 per day
- **Scalp thinning** typically most noticeable at the crown and temples; hairline is usually preserved
- **Hair found everywhere** — on pillows, in the shower, in hair brushes, on clothing
- **New fine hairs (fringe)** along the hairline — short regrowing hairs, a positive sign of recovery
- **No scalp rash, scaling, itch, or pain** — if these are present, an alternative or concurrent diagnosis ([seborrheic dermatitis](/seborrheic-dermatitis-scalp), [psoriasis](/psoriasis-skin-guide), fungal infection) should be considered
- **Beau's lines on nails** (transverse grooves) may coincide, reflecting the same systemic stress event in the timeline

Patients do not develop complete baldness. Even at peak shedding, TE leaves the scalp thinned but not bald. This distinguishes it from other alopecias such as androgenetic alopecia, where permanent follicle miniaturisation occurs, or alopecia areata, which produces focal patches.

---

## Diagnosis

In most cases, a thorough history and physical examination are sufficient to diagnose TE.

**History** should identify:
- Any significant illness, surgery, trauma, childbirth, or dietary change in the preceding 1–6 months (the causative event is frequently 3 months prior and may have been fully resolved by the time the patient presents)
- Medication changes
- Dietary habits — protein intake, crash dieting
- Menstrual history and contraceptive use

**Physical examination:**
- Diffuse thinning across the scalp, typically greater at the crown
- **Hair pull test** — grasping 40–60 hairs between two fingers and applying gentle traction; extracting 4 or more hairs constitutes a positive result. Normal: 2–3 hairs. Note: this test may be negative in resolving TE.
- Short regrowing hairs at the hairline confirm recent shedding followed by regrowth

**Laboratory investigations** are warranted when no clear trigger is apparent or when the condition is chronic:

| Test | What it screens for |
|---|---|
| Full blood count | Anemia |
| Serum ferritin | Iron deficiency (even without anemia) |
| TSH, T3, T4 | Thyroid dysfunction |
| Zinc and vitamin D | Nutritional deficiency |
| ANA / inflammatory markers | Autoimmune conditions |

**Scalp biopsy** is reserved for cases lasting beyond 6 months or where the diagnosis is in doubt. Histology shows an increased proportion of follicles in the telogen phase — diagnostically significant when >25% of follicles are telogen on biopsy (normal: ~15%). Biopsy also helps distinguish TE from androgenetic alopecia (which shows follicular miniaturisation) and alopecia areata (which shows a lymphocytic infiltrate around the bulb).

**Trichogram** (microscopic examination of plucked hairs) showing >25% telogen hairs confirms the diagnosis; >15% is suggestive.

---

## Treatment

### Step 1: Address the trigger

Acute TE is self-limiting. If the underlying cause has resolved spontaneously (e.g., recovery from illness, postpartum hormonal normalisation), no specific hair treatment is required. The most important clinical action is identifying and correcting any ongoing cause:

- **Iron deficiency:** ferrous sulfate 300 mg three to four times daily for 3–6 months; recheck ferritin at 3 months. Target serum ferritin >40 ng/mL.
- **Thyroid dysfunction:** thyroid hormone replacement or management per endocrinologist
- **Nutritional deficiency:** dietary assessment; protein intake of at least 40–60 g per day recommended
- **Medication-induced TE:** discuss alternatives with the prescribing clinician; shedding typically reverses after discontinuation

### Step 2: Supportive care

- Gentle hair handling — no evidence that normal washing or styling accelerates TE, and patients should be reassured on this point
- Reduce chemical and heat damage to minimize additional mechanical hair loss
- Manage stress — psychological TE may perpetuate if stress remains unaddressed

### Step 3: Pharmacological options (where indicated)

**Topical minoxidil (2% or 5%)** extends the anagen phase and is the most commonly used pharmacological adjunct. Results in TE are variable. Patients should be counselled on the initial "shedding phase" when starting minoxidil (see type 4 — immediate telogen release) and the need for continuous use.

**Oral minoxidil** at low doses (0.25–2.5 mg once daily) has shown more consistent results in chronic TE. A retrospective study of 36 women (mean age 46.9 years) treated for a mean disease duration of 6.55 years showed significant reduction in hair shedding scores from baseline to 6 months (p<0.001) and further improvement at 12 months; 33 of 36 patients improved. The main side effect was unwanted facial hair growth, seen in 13 patients. Oral minoxidil for CTE should be managed by a dermatologist.

---

## Timeline and Prognosis

| Stage | Timing |
|---|---|
| Triggering event | Day 0 |
| Shedding begins | 2–3 months post-trigger |
| Shedding peaks | 3–4 months post-trigger |
| Shedding tapers | 4–6 months post-trigger |
| New hair growth visible | 6–9 months post-trigger |
| Full cosmetic recovery | Up to 12–18 months |

Acute TE resolves spontaneously in approximately **95% of cases** once the trigger is removed. Recovery may feel slow — the first evidence of improvement is a reduction in shedding rather than obvious new growth, and patients need to understand this normal course to avoid anxiety-driven over-treatment.

Full regrowth is the expected outcome. TE does not scar the scalp or permanently damage follicles. Patients with a concurrent underlying condition (such as female-pattern hair loss) may not recover their full pre-TE density, as TE can unmask a pre-existing androgenetic process.

---

## When to See a Dermatologist

Self-managing suspected TE is reasonable in the short term when a clear trigger exists and the condition began acutely. However, consult a dermatologist if:

- Shedding has continued for **more than 6 months** (meets criteria for chronic TE)
- No clear triggering event can be identified
- Hair loss is patchy rather than diffuse (suggests an alternative diagnosis)
- The scalp shows redness, scaling, pain, or pustules
- Standard laboratory tests ordered by your GP are normal but shedding continues
- Shedding is causing significant psychological distress

---

## Myths and Misconceptions

The most persistent myths about telogen effluvium:

**"It means my hair follicles are permanently damaged."** False — TE is a cycle-timing disorder. The follicles are intact. The hair that shed has a normal club root (white keratin bulb), not a damaged papilla.

**"Washing my hair less will slow the shedding."** False — hairs in the telogen phase will fall regardless of washing frequency. Reducing washing does not prevent shedding; it only causes the shed hairs to accumulate and fall in larger apparent volumes when you do wash.

**"Stress alone causes massive, permanent hair loss."** Stress is a genuine trigger for TE, but the resulting shedding is temporary. When the stress is resolved or managed, hair returns. Chronic unremitting stress may prolong the condition, but even then, follicles retain their capacity for regrowth.

## FAQ
**Is telogen effluvium permanent, or will hair grow back in 2026?**

Telogen effluvium is not permanent. The hair follicles are structurally intact — the condition disrupts the timing of the hair cycle, not the follicle itself. Acute TE resolves in approximately 95% of cases within 6–9 months once the trigger is identified and addressed. Full cosmetic density may take 12–18 months to fully restore. The 2026 consensus from dermatologists remains unchanged: TE is a benign, reversible condition in the vast majority of patients.

**Why does hair fall out months after the stressful event, not during it?**

Because telogen effluvium is a delayed consequence of the hair cycle being disrupted. When a stressor hits, follicles are pushed from the anagen (growth) phase into the telogen (resting) phase almost immediately. But telogen lasts roughly 3 months — so the visible shedding does not occur until those resting hairs are shed 2–3 months after the trigger. This timing is why patients often don't connect the hair loss to the original event.

**How is telogen effluvium different from androgenetic alopecia (pattern baldness)?**

Telogen effluvium is diffuse (affecting the whole scalp evenly), temporary, and involves no follicle miniaturisation. Androgenetic alopecia (female or male pattern hair loss) involves progressive, permanent miniaturisation of follicles in a patterned distribution — hairline recession in men, crown thinning in women — and does not spontaneously reverse. The two conditions can coexist: TE can unmask underlying androgenetic alopecia that was previously subclinical. A dermatologist can distinguish them with a pull test, trichoscopy, and if needed a scalp biopsy.

**What blood tests should be done to investigate telogen effluvium?**

The standard workup includes: full blood count (to check for anemia), serum ferritin (iron stores — even non-anemic deficiency can drive TE; ferritin below 20–40 ng/mL is clinically significant), TSH with free T3 and T4 (thyroid function), zinc, and vitamin D. If autoimmune conditions are suspected, an ANA and inflammatory markers may be added. These tests are typically ordered by a GP or dermatologist.

**Does biotin supplementation help telogen effluvium?**

Only if you have a biotin deficiency, which is rare. The widespread marketing of biotin for hair loss far outpaces the evidence. No well-designed clinical trial demonstrates that biotin supplementation improves hair shedding in people with adequate biotin status. However, biotin deficiency itself (uncommon) does cause hair loss, and correcting it restores growth. Before supplementing, a dermatologist can order a biotin level test — testing is more useful than routine supplementation.

**Can telogen effluvium come back after it resolves?**

Yes. Telogen effluvium is not a one-time condition — any significant new stressor can trigger another episode. People who have had TE once are not more vulnerable than the general population to future episodes, but they may recognize the pattern more quickly. Individuals with chronic TE may experience a fluctuating, relapsing course over years.

## When to see a professional
Consult a dermatologist if: shedding has persisted for more than 6 months (meeting the definition of chronic TE); no identifiable trigger can be found; hair loss is patchy rather than diffuse; the scalp shows redness, scaling, itch, or pustules; standard GP blood tests are normal but shedding continues; or hair loss is causing significant psychological distress. Early investigation of chronic TE is important to identify and treat correctable systemic causes before they produce other health consequences.

## Sources
- Telogen Effluvium — StatPearls — NCBI Bookshelf / StatPearls (NIH) (2023-08-14): https://www.ncbi.nlm.nih.gov/books/NBK430848/
- Telogen Effluvium: A Review of the Literature — PubMed Central / NIH (PMC7320655) (2020-06-22): https://pmc.ncbi.nlm.nih.gov/articles/PMC7320655/
- Telogen Effluvium: A Review — PubMed Central / NIH (PMC4606321) (2015-10-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC4606321/
- Telogen Effluvium (Hair Shedding) — DermNet NZ (2023-06-01): https://dermnetnz.org/topics/telogen-effluvium
- Treatment of Chronic Telogen Effluvium with Oral Minoxidil: A Retrospective Study — PubMed Central / NIH (PMC5676194) (2017-10-01): https://pmc.ncbi.nlm.nih.gov/articles/PMC5676194/
- Telogen Effluvium: Symptoms, Causes, Treatment & Regrowth — Cleveland Clinic (2023-09-01): https://my.clevelandclinic.org/health/diseases/24486-telogen-effluvium
- Do You Have Hair Loss or Hair Shedding? — American Academy of Dermatology (AAD): https://www.aad.org/public/diseases/hair-loss/insider/shedding

_Health information, not medical advice._